Great Debates & Updates in Hematologic Malignancies is a multi-day, debate-driven conferences focusing on the treatment of blood cancer. Attendees can expect a comprehensive overview of the most significant advances in multiple myeloma, acute and chronic lymphocytic and myeloid leukemia, lymphoma, as well as take-home information to immediately implement in your practice.
The unique format will include didactic presentations and lively and interactive debates, covering some of the most controversial and relevant topics in the field. These conferences are sure to be an engaging, interactive educational opportunity for attendees allowing for the ability to network with both faculty and attendees alike.
Stay tuned for more information about our 2023 events.
The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, such as multiple myeloma, acute and chronic lymphocytic and myeloid leukemia, lymphoma, and so much more.
These live educational activities are designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, and myeloid malignancies.
As an event best known for its unique, debate-style format, the 2022 agenda features a mix of didactic lectures and debates, examining the latest and most controversial topics across the board in the field of hematologic malignancies.
Robert H. Lurie Comprehensive Cancer Center
Executive Vice Chair, Weill Department of Medicine
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/New York Presbyterian
New York, New York
Translational Genomics Research Institute, City of Hope Cancer Center